TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 160 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q2 2016. The put-call ratio across all filers is 0.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $5,401,000 | -6.4% | 54,947 | +10.1% | 0.04% | -7.1% |
| Q2 2018 | $5,771,000 | +16.3% | 49,890 | -0.7% | 0.04% | +16.7% |
| Q1 2018 | $4,961,000 | -3.4% | 50,243 | +2.4% | 0.04% | 0.0% |
| Q4 2017 | $5,138,000 | -15.1% | 49,061 | -9.1% | 0.04% | -7.7% |
| Q3 2017 | $6,049,000 | 0.0% | 53,976 | 0.0% | 0.04% | -30.4% |
| Q2 2017 | $6,049,000 | -2.0% | 53,976 | +2.0% | 0.06% | -3.4% |
| Q1 2017 | $6,172,000 | +9.1% | 52,912 | -1.6% | 0.06% | +9.4% |
| Q4 2016 | $5,659,000 | -8.8% | 53,754 | -4.3% | 0.05% | -8.6% |
| Q3 2016 | $6,205,000 | +41266.7% | 56,149 | +56049.0% | 0.06% | – |
| Q2 2016 | $15,000 | +7.1% | 100 | 0.0% | 0.00% | – |
| Q1 2016 | $14,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 85,205 | $9,416,000 | 7.01% |
| FORT, L.P. | 149,014 | $16,468,000 | 5.67% |
| Strategic Global Advisors, LLC | 80,231 | $11,336,000 | 4.23% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 701,900 | $77,567,000 | 3.19% |
| Ativo Capital Management LLC | 78,727 | $8,700,000 | 2.01% |
| Analyst IMS Investment Management Services Ltd. | 31,438 | $3,474,000 | 1.47% |
| Parametrica Management Ltd | 4,327 | $478,000 | 1.32% |
| Freestone Capital Holdings, LLC | 89,005 | $9,836,000 | 0.90% |
| RPG Investment Advisory, LLC | 19,580 | $2,163,000 | 0.68% |
| MERITAGE PORTFOLIO MANAGEMENT | 38,465 | $4,251,000 | 0.47% |